| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:484857084:2055 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:484857084:2055?format=raw |
LEADER: 02055cam a2200445 a 4500
001 3934805
005 20221027003518.0
008 880720t19731973nyua b 101 0 eng d
010 $a 73161964
020 $a0911216472
035 $a(OCoLC)663208
035 $a(OCoLC)ocm00663208
035 $a(CStRLIN)NYCM88-B2851
035 $9ADJ7765HS
035 $a(NNC)3934805
035 $a3934805
040 $dNNC-M
050 00 $aRC382$b.T7
082 0 $a616.8/33/061
245 00 $aTreatment of Parkinsonism :$bthe role of dopa decarboxylase inhibitors /$cEdited by Melvin D. Yahr.
260 $aNew York :$bRaven Press,$c[1973], ©1973.
300 $axiv, 303 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in neurology ;$vv. 2
500 $aTables.
500 $aIncludes indexes.
500 $a"Contains the major presentations of a meeting held on November 28, 1972, under the joint sponsorship of the Parkinson's Disease Foundation and Merck Sharp & Dohme Research Laboratories."
504 $aBibliography: p. 279-296.
650 0 $aParkinson's disease$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2010105130
650 0 $aAromatic amino acid decarboxylases$xInhibitors$xTherapeutic use$vCongresses.
650 2 $aEnzyme Inhibitors.$0https://id.nlm.nih.gov/mesh/D004791
650 2 $aAromatic-L-Amino-Acid Decarboxylases$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D001142Q000627
650 2 $aParkinson Disease.$0https://id.nlm.nih.gov/mesh/D010300
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aYahr, Melvin D.$q(Melvin David),$d1917-2004.$0http://id.loc.gov/authorities/names/n50013966
710 2 $aParkinson's Disease Foundation (U.S.)$0http://id.loc.gov/authorities/names/n83044606
710 2 $aMerck Sharp & Dohme.$0http://id.loc.gov/authorities/names/n80106630
830 0 $aAdvances in neurology ;$vv. 2.$0http://id.loc.gov/authorities/names/n42001240
852 00 $boff,hsl$hRC321$i.A276 1973 v.2